Chemical Compound

Lenoremycin

CAS Registry Number 51257-84-2
Back to search Request a Quote
Lenoremycin chemical structure
Primary Record

Lenoremycin

In stock
4,914 g
Purity
99.8 %
CAS
51257-84-2

Compound Identifiers & Properties

CAS
51257-84-2
PubChem CID
6441669
SMILES
C[C@@H]1CC[C@@H](O[C@@]12[C@H](C[C@@H](O2)[C@@H]3[C@H](C[C@H]([C@@](O3)(CO)O)C)C)C)[C@@]4(CC[C@@]5(O4)[C@@H]([C@@H](C[C@H](O5)[C@@H](C)/C=C(\C)/C(=O)[C@H](C)C[C@H](C)C(=O)O)O[C@H]6CC[C@@H]([C@H](O6)C)OC)C)C
Canonical SMILES
CO[C@H]1CC[C@H](O[C@@H]2C[C@@H]([C@@H](C)/C=C(\C)C(=O)[C@H](C)C[C@H](C)C(=O)O)O[C@@]3(CC[C@@](C)([C@H]4CC[C@@H](C)[C@@]5(O[C@@H]([C@H]6O[C@@](O)(CO)[C@H](C)C[C@@H]6C)C[C@@H]5C)O4)O3)[C@@H]2C)O[C@@H]1C

Names & Synonyms

  • Lenoremycin
  • Antibiotic A 130A
  • Antibiotic A-130A
  • Lenoremycin sodium salt
  • A-130A
  • Antibiotic Ro 21 6150
  • AC1O5VQZ
  • RefChem:108351
  • DTXSID701318162
  • orb1702632
  • 51257-84-2
  • CHEMBL4098414
  • SCHEMBL29370393
  • DTXCID001747950
  • A 130C
  • BBF-03028
  • AKOS040746494
  • CID6441669
  • C47-H78-O13
  • A 130
  • Ro-21-6150
  • LS-59585
  • A-130
  • CS-0107499
  • J3.615.028I
  • (11(2R,5S,6R),12R)-10-Demethyl-19-de((tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)oxy)-12-methyl-11-O-(tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)dianemycin
  • (2S,4R,8S,E)-8-((2S,2'R,4'S,5R,5'R,7S,7'R,9R,10R,10'R)-2'-((2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl)-9-(((2R,5S,6R)-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,4',10,10'-tetramethyl-1,1',6,6'-tetraoxa[2,7'-bispiro[4.5]decan]-7-yl)-2,4,6-trimethyl-5-oxonon-6-enoic acid
  • (E,2S,4R,8S)-8-[(2S,5R,6R,7R,9S)-2-[(2R,4S,5R,6R,9R)-2-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-4,6-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-7-[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-2,6-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2,4,6-trimethyl-5-oxonon-6-enoic acid
  • Dianemycin, 10-demethyl-19-de((tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)oxy)-12-methyl-11-O-(tetrahydro-5-methoxy-6-methyl-2H-pyran-2-yl)-, (11R(2R,5S,6R),12R)
  • (2S,4R,6E,8S)-8-[(2S,5R,7S,9R,10R)-2-[(2R,4S,5R,7R,10R)-2-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-4,10-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-9-{[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy}-2,10-dimethyl-1,6-dioxaspiro[4.5]decan-7-yl]-2,4,6-trimethyl-5-oxonon-6-enoic acid
  • (2S,4R,6E,8S)-8-[(4'S,5R,5'R,7S,7'R,9R,10R,10'R)-2'-[(3S,5R,6R)-6-Hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-9-{[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy}-2,4',10,10'-tetramethyl[1,1',6,6'-tetraoxa-2,7'-bi(spiro[4.5]decan)]-7-yl]-2,4,6-trimethyl-5-oxonon-6-enoic acid
  • (E,2S,4R,8S)-8-((2S,5R,6R,7R,9S)-2-((2R,4S,5R,6R,9R)-2-((2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl)-4,6-dimethyl-1,10-dioxaspiro(4.5)decan-9-yl)-7-((2R,5S,6R)-5-methoxy-6-methyloxan-2-yl)oxy-2,6-dimethyl-1,10-dioxaspiro(4.5)decan-9-yl)-2,4,6-trimethyl-5-oxonon-6-enoic acid
  • (E,2S,4R,8S)-8-[(2S,5R,7S,9R,10R)-2-[(2R,4S,5R,7R,10R)-2-[(2S,3S,5R,6R)-6-Hydroxy-6-(hydroxymethyl)-3,5-dimethyltetrahydro-2H-pyran-2-yl]-4,10-dimethyl-1,6-dioxaspiro[4.5]decane-7-yl]-9-[(2R,5S,6R)-5-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy-2,10-dimethyl-1,6-dioxaspiro[4.5]decane-7-yl]-2,4,6-trimethyl-5-oxo-6-nonenoic acid
  • (E,2S,4R,8S)-8-[(3S,5R,6R,7R,9S)-3-[(1S,3R,5R,6R,9R)-3-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-1,6-dimethyl-4,10-dioxaspiro[4.5]decan-9-yl]-7-[(2R,5S,6R)-5-methoxy-6-methyloxan-2-yl]oxy-3,6-dimethyl-4,10-dioxaspiro[4.5]decan-9-yl]-2,4,6-trimethyl-5-oxonon-6-enoic acid
  • 3-ETHYL-2-(3-ETHYL-4,5-DIPHENYL-THIAZOLIUM-2-YL-METHYLENE)-5-[2-(1-ETHYL-1H-QUINOLIN-4-YLIDENE)-ETHYLIDENE]-THIAZOLIDIN-4-ONE BROMIDE